Seeing Is Believing
with an average price target of $4.65. This is a potential upside of $4.65 (0%) from yesterday's end of day stock price of $0.
Jounce Therapeutics's activity chart (see below) currently has 34 price targets and 28 ratings on display.
Analysts average stock forecasts to be materialized ratio is 15.63% with an average time for these price targets to be met of 262 days.
Most recent stock forecast was given by MICHAEL ULZ from MORGAN STANLEY on 28-Mar-2023.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$2
$0.12 (6.38%)
$7
2 years 2 months 20 days ago
(28-Mar-2023)
0/4 (0%)
$0.16 (8.70%)
Hold
$3
2 years 3 months 25 days ago
(23-Feb-2023)
2/8 (25%)
$1.83 (156.41%)
622
Buy
$5
$3.12 (165.96%)
$9
2 years 5 months 14 days ago
(03-Jan-2023)
0/4 (0%)
$3.91 (358.72%)
Buy
$11
$9.12 (485.11%)
$15
2 years 10 months 12 days ago
(05-Aug-2022)
0/2 (0%)
$6.84 (164.42%)
Buy
$15
$13.12 (697.87%)
$15
3 years 1 months 5 days ago
(12-May-2022)
0/4 (0%)
$10.75 (252.94%)
What is JNCE (Jounce Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on JNCE (Jounce Therapeutics) with a proven track record?
Which analyst has the current lower performing score on JNCE (Jounce Therapeutics) with a proven track record?
Which analyst has the most public recommendations on JNCE (Jounce Therapeutics)?
Which analyst is the currently most bullish on JNCE (Jounce Therapeutics)?
Which analyst is the currently most reserved on JNCE (Jounce Therapeutics)?